Additionally, it has been observed that levels of asprosin in the bloodstream are higher in specific metabolic disorders such as type 2 diabetes mellitus (T2DM), obesity, polycystic ovary syndrome, gestational diabetes mellitus, and cardiometabolic diseases13. Here, FBN1 is linked to Other metabolic disease.